FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Catheter, Coronary, Atherectomy

PMA: P900056 · Supplement: S185 · Decision Jun 16, 2020
Classifications
1
FEI Numbers
22
Registration Numbers
22

Basic Information

Device Name
Catheter, Coronary, Atherectomy
Trade Name
Rotablator Rotational Atherectomy System, ROTAPRO Rotational Atherectomy System
PMA Number
P900056
Supplement Number
S185
Device Class
FDA Class 3
Product Code
MCX
Generic Name
CATHETER, CORONARY, ATHERECTOMY
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
June 16, 2020
Date Received
May 22, 2020
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Modifications to associated acceptance activities/inspections for the supplied infusion hose assembly for Rotalink and Rotapro advancers.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MCX Catheter, Coronary, Atherectomy